US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 23, 2016 (10 years ago)

Diazepam Injection USP 10mg/2mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Crystallization: Product contains particulate identified to be crystallized active ingredient.

What was recalled

Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32

Recalling firm
Hospira Inc.
NDC code
0409-1273-32
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1359-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Diazepam recalls

See all
Class II · Moderate risk Terminated

Diazepam Oral Solution

Reason Failed Impurities/Degradation Specifications: Out of specification results for related substances.

Lannett Company, Inc. NDC 0527-1768-36 D-0558-2022
Class III · Low risk Terminated

Diazepam Rectal Gel

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Valeant Pharmaceuticals North America LLC NDC 68682-650-20 D-1041-2018
Class II · Moderate risk Terminated

Diazepam 5 mg/mL injectable packaged in an amber glass injectable vial

Reason Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Martin Avenue Pharmacy, Inc. D-0078-2015
Class II · Moderate risk Terminated

Diazepam Injection

Reason Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.

Hospira Inc. NDC 0409-3213-12 D-927-2013